About Daniel Haymann

Daniel Haymann specialises in corporate and commercial law with a focus on investments, venture capital and financing transactions, as well as on regulatory issues in the healthcare and consumer goods sectors, including THC, CBD and other cannabinoids and psychedelic compounds. Daniel is the co-founder and co-chair of the European offshoot of the International Cannabis Bar Association (INCBA Europe).

Contributions to Global Practice Guides

Medical Cannabis & Cannabinoid Regulation Trends and Developments in Switzerland

Medical Cannabis & Cannabinoid Regulation Law and Practice in Switzerland

Medical Cannabis & Cannabinoid Regulation Introduction

}

Chambers and Partners make no representation or endorsement of the quality and services supplied by companies or firms that may be found on this website. In no event will Chambers and Partners be liable for any damages including, without limitation, indirect or consequential damages, or any damages whatsoever arising from use or loss of use, data, or profits, whether in action of contract, negligence or other tort action, arising out of or in connection with the use of the website.